Prostamax Guia & Tabela de Dose

What is Prostamax?

Prostamax is a short-chain peptide bioregulator — a tiny protein fragment made up of just four amino acids: Lysine, Glutamic acid, Aspartic acid, and Proline (Lys-Glu-Asp-Pro).^[4] It belongs to a family of compounds called peptide bioregulators, which are short signaling molecules that researchers believe help cells function more normally, especially as organisms age. Prostamax was originally developed with a focus on prostate tissue, and studies have tested it on prostate gland explants in animal models.^[5] It is currently a research-use-only compound — not approved for human therapeutic use — and everything on this page reflects laboratory and early-stage research findings only.

How Prostamax Works

Think of your DNA like a tightly wound ball of yarn. Genes that the cell is not currently using get packed away deep inside that ball — this tightly packed state is called heterochromatin. As we age, more and more genes get locked away unnecessarily, a bit like filing important documents in a box and losing the key. Researchers think this contributes to how cells age and lose function.

Prostamax appears to act on chromatin — the material that DNA is wound around — in a way that loosens this tight packaging. Scientists call this process deheterochromatinization: essentially, unpacking those locked-away genes so they can potentially be read again.^[3] Laboratory measurements using a technique called microcalorimetry (which tracks heat changes during DNA unfolding) have shown that Prostamax shifts how chromatin unfolds, suggesting real structural changes are happening at the molecular level.^[1]

What the Research Shows

A handful of peer-reviewed studies have examined what Prostamax does in cell cultures and animal tissue. Here is a plain-language breakdown:

• Chromatin loosening in aged human cells: Researchers exposed lymphocytes (a type of white blood cell) from elderly people aged 75–88 to Prostamax alongside other short peptides. Prostamax, like the other peptides tested, triggered activation of ribosome genes, loosened tightly packed chromatin fibers, and released genes that had been effectively silenced by age-related chromatin condensation.^[3]
• Chromosome-level changes: A separate study looked at specific chromosome landmarks in cells from people aged 75–86. After Prostamax treatment, the frequency of sister chromatid exchanges (a marker of DNA repair activity) jumped from about 5.9 to 12.0 per cell. The number of active nucleolar organizer regions — areas responsible for making the cellular machinery that builds proteins — also rose significantly. The researchers concluded that Prostamax can decondense chromatin and release genes that aging had repressed.^[4]
• DNA structural measurements: Using a heat-based analysis technique, scientists showed that Prostamax causes measurable shifts in how human lymphocyte chromatin unfolds under heat stress, pointing to real physical changes in the DNA–protein packaging structure.^[1]
• Interaction with heavy metals: One study looked at how Prostamax interacts with copper and cadmium ions in aged lymphocyte cultures. The researchers found that different ions affected chromatin in different ways — copper tended to condense it further, while cadmium caused decondensation — providing context for how Prostamax's own chromatin effects compare to environmental stressors.^[2]
• Prostate tissue stimulation in rats: In a tissue culture experiment using explants (small pieces of living tissue grown in a dish) from young and old rats, Prostamax at a concentration of just 0.05 ng/ml stimulated growth activity in prostate gland tissue compared to untreated controls. Similar tissue-specific effects were seen for other peptides tested on heart, lung, and pancreas tissue.^[5]
• Evolutionary context: Research into long-lived animals like the naked mole rat found that short epigenetically active peptides — the same class as Prostamax — appear in the proteins of long-lived species but are sometimes absent in short-lived ones, suggesting these peptide sequences may play a meaningful role in longevity biology.^[6]

What Prostamax Is Being Studied For

In research settings, Prostamax is primarily being explored for its potential effects on:

• Prostate tissue biology — specifically how it may support or stimulate prostate gland cells, particularly in aged tissue models.^[5]
• Epigenetic aging — the idea that age-related gene silencing (heterochromatinization) can be partially reversed by short peptides like Prostamax.^[3][4]
• Cellular gerontology — understanding how short bioregulatory peptides influence the biology of aging at the chromosome and chromatin level.^[6]

This is early-stage, laboratory-based research. No clinical trials in humans have established Prostamax as a treatment for any condition.

How Prostamax Is Dosed in Research

Because dosing protocols for Prostamax are still being defined by researchers, there are no universally agreed-upon standard doses. The one animal tissue study identified an effective concentration as low as 0.05 ng/ml in an organotypic culture model.^[5] For guidance on how research teams have structured their protocols, refer to the dosage chart on this page, and use the calculator to help work out concentrations once a peptide has been reconstituted. Remember: these tools are for research planning only.

Mixing and Storing Prostamax

Prostamax, like most research peptides, typically arrives as a lyophilized powder — meaning it has been freeze-dried to extend shelf life. To use it in a research setting, it needs to be reconstituted (dissolved) in a suitable liquid, most commonly bacteriostatic water or sterile saline, added slowly down the side of the vial to avoid damaging the peptide. Swirl gently — never shake — until fully dissolved. Once mixed, store the solution in a refrigerator (2–8°C) and use within a few weeks; unmixed powder can typically be kept frozen for longer periods. Always check your supplier's specific storage recommendations. Keep all solutions away from repeated freeze-thaw cycles, as this can degrade the peptide.

Sources

1. [The influence of the peptide bioregulator prostamax on heterochromatin of human lymphocytes in situ]. — Biofizika, 2004. PMID 15612551.
2. Microcalorimetric study of human blood lymphocytes culture at presence of copper, cadmium and prostamax. — Georgian medical news, 2009. PMID 19359734.
3. Effects of short peptides on lymphocyte chromatin in senile subjects. — Bulletin of experimental biology and medicine, 2004. PMID 15085253.
4. [Deheterochromatinization of the chromatin in old age induced by oligopeptide bioregulator (Lys-Glu-Asp-Pro)]. — Georgian medical news, 2012. PMID 23221144.
5. [The tissue-specific effect of synthetic peptides-biologic regulators in organotypic tissues culture in young and old rats]. — Advances in gerontology = Uspekhi gerontologii, 2006. PMID 17152728.
6. Peptides (Epigenetic Regulators) in the Structure of Rodents with a Long and Short Lifespan. — Bulletin of experimental biology and medicine, 2017. PMID 28948547.